OMIC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OMIC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Singular Genomics Systems's Average Total Inventories for the three months ended in Mar. 2024 was $13.33 Mil. Singular Genomics Systems's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.86 Mil. Hence, Singular Genomics Systems's Days Inventory for the three months ended in Mar. 2024 was 1,412.36.
The historical rank and industry rank for Singular Genomics Systems's Days Inventory or its related term are showing as below:
During the past 5 years, Singular Genomics Systems's highest Days Inventory was 4911.08. The lowest was 1483.35. And the median was 3291.84.
Singular Genomics Systems's Days Inventory declined from Mar. 2023 (2,000.32) to Mar. 2024 (1,412.36).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year. Singular Genomics Systems's Inventory Turnover for the three months ended in Mar. 2024 was 0.06.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Singular Genomics Systems's Inventory-to-Revenue for the three months ended in Mar. 2024 was 30.15.
The historical data trend for Singular Genomics Systems's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Genomics Systems Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Days Inventory | - | - | - | 4,911.08 | 1,672.59 |
Singular Genomics Systems Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Days Inventory | Get a 7-Day Free Trial | 2,000.32 | 2,408.42 | 2,404.53 | 800.72 | 1,412.36 |
For the Medical Instruments & Supplies subindustry, Singular Genomics Systems's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Singular Genomics Systems's Days Inventory distribution charts can be found below:
* The bar in red indicates where Singular Genomics Systems's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Singular Genomics Systems's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (18.221 | + | 13.572) | / | 2 ) | / | 3.469 | * | 365 |
= | 15.8965 | / | 3.469 | * | 365 | ||||
= | 1,672.59 |
Singular Genomics Systems's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:
Days Inventory (Q: Mar. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Dec. 2023 ) | + | Total Inventories (Q: Mar. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2024 ) | * | Days in Period |
= | ( (13.572 | + | 13.081) | / | 2 ) | / | 0.861 | * | 365 / 4 |
= | 13.3265 | / | 0.861 | * | 365 / 4 | ||||
= | 1,412.36 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Genomics Systems (NAS:OMIC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Singular Genomics Systems's Inventory Turnover for the three months ended in Mar. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.861 | / | 13.3265 | |
= | 0.06 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Singular Genomics Systems's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 13.3265 | / | 0.442 | |
= | 30.15 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Singular Genomics Systems's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew Spaventa | director, 10 percent owner, officer: Chief Executive Officer | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
Eli N. Glezer | officer: Chief Scientific Officer | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
Jyotsna Ghai | officer: Chief Operating Officer | 3010 SCIENCE PARK ROAD, SAN DIEGO CA 92121 |
Kim P. Kamdar | director | C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542 |
Marcia Eisenberg | director | C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210 |
Sam Ropp | officer: Chief Commercial Officer | 3010 SCIENCE PARK ROAD, SAN DIEGO CA 92121 |
Michael J Pellini | director | 222 DUTTON MILL RD, WILLISTOWN PA 19380 |
Elaine R Mardis | director | 301 MERRITT 7, NORWALK CT 06851 |
James E Flynn | 10 percent owner, other: *Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
David Daly | officer: President and Chief Operating | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
Vincent Brancaccio | officer: Vice President, HR | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
Dalen Meeter | officer: Vice President, Finance | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
Daralyn Durie | officer: General Counsel | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
Jorge Velarde | officer: Senior Vice President | 10931 N. TORREY PINES ROAD, SUITE 100, LA JOLLA CA 92037 |
David L Barker | director | 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121 |
From GuruFocus
By GlobeNewswire • 01-07-2024
By Marketwired • 09-08-2023
By sperokesalga sperokesalga • 05-09-2023
By PurpleRose PurpleRose • 07-13-2022
By Marketwired • 07-26-2023
By PurpleRose PurpleRose • 08-02-2022
By PurpleRose PurpleRose • 08-18-2022
By Marketwired • 08-08-2023
By GuruFocusNews GuruFocusNews • 07-09-2022
By GuruFocusNews GuruFocusNews • 07-09-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.